New Safety Information For Women Using Dolutegravir, A Medication Used To Treat Hiv Infection

Dolutegravir HIV Medication Safety Update Health authorities have issued new safety information for women taking dolutegravir, a medication used to treat HIV infection. The update concerns potential risks associated with the medication in women of childbearing age. The alert applies to all women across Canada who are currently using or considering dolutegravir.

Reason
Product safety
Category
consumer product recall
Country
Canada
Agency
HC-PRODUCTS
Recall date
2018-06-07
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/e25a3a09-fc65-4c74-870a-ca8f25d738f4